| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
4,468 |
3,895 |
$118K |
| 70450 |
Computed tomography, head or brain; without contrast material |
726 |
658 |
$89K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,703 |
1,604 |
$62K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,258 |
5,217 |
$50K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
271 |
257 |
$50K |
| 84484 |
|
1,580 |
1,303 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,487 |
1,252 |
$32K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
886 |
208 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
1,257 |
1,162 |
$27K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
292 |
247 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
1,732 |
1,367 |
$24K |
| 83880 |
|
964 |
833 |
$24K |
| 80306 |
|
1,232 |
1,092 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
960 |
918 |
$21K |
| 87400 |
|
1,629 |
1,539 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,975 |
1,631 |
$18K |
| 83605 |
|
1,104 |
954 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
244 |
233 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,172 |
1,131 |
$13K |
| 83690 |
|
1,081 |
978 |
$13K |
| 83735 |
|
1,502 |
1,272 |
$12K |
| 71045 |
Radiologic examination, chest; single view |
1,314 |
1,176 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
239 |
232 |
$11K |
| 81025 |
|
881 |
799 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
43 |
37 |
$8K |
| 87081 |
|
817 |
789 |
$8K |
| 81001 |
|
1,772 |
1,619 |
$7K |
| 80061 |
Lipid panel |
658 |
633 |
$6K |
| 81003 |
|
1,402 |
1,279 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
577 |
508 |
$5K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
243 |
179 |
$5K |
| 85610 |
|
1,136 |
982 |
$4K |
| 80050 |
General health panel |
119 |
113 |
$4K |
| 87807 |
|
308 |
299 |
$4K |
| 86140 |
|
599 |
535 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
65 |
60 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
71 |
66 |
$3K |
| 85730 |
|
454 |
398 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
836 |
732 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
314 |
249 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
445 |
430 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
241 |
234 |
$2K |
| 71020 |
|
120 |
114 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
719 |
638 |
$1K |
| 87040 |
|
76 |
66 |
$1K |
| 87077 |
|
96 |
91 |
$1K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14 |
12 |
$1K |
| 84145 |
|
66 |
55 |
$976.72 |
| 82077 |
|
62 |
54 |
$960.81 |
| 82962 |
|
68 |
57 |
$715.18 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
15 |
$712.43 |
| 87186 |
|
96 |
91 |
$709.90 |
| 85379 |
|
38 |
36 |
$394.87 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18 |
14 |
$379.35 |
| 80320 |
|
34 |
27 |
$377.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
660 |
564 |
$366.05 |
| 73130 |
|
13 |
13 |
$256.75 |
| 82728 |
|
12 |
12 |
$238.22 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
702 |
606 |
$198.83 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
410 |
383 |
$197.94 |
| 85651 |
|
16 |
14 |
$115.32 |
| 87088 |
|
16 |
13 |
$94.63 |
| 84439 |
|
12 |
12 |
$51.52 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
40 |
38 |
$9.10 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
45 |
39 |
$5.06 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
14 |
14 |
$3.28 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
232 |
208 |
$0.00 |
| A9270 |
Non-covered item or service |
56 |
37 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
17 |
13 |
$0.00 |